Wan Y - Search Results

1

Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2.

Gorczynski RM, Bransom J, Cattral M, Huang X, Lei J, Xiaorong L, Min WP, Wan Y, Gauldie J. Gorczynski RM, et al. Among authors: wan y. Clin Immunol. 2000 Jun;95(3):182-9. doi: 10.1006/clim.2000.4860. Clin Immunol. 2000. PMID: 10866124

2

Dendritic cells expressing TGFbeta/IL-10, and CHO cells with OX-2, increase graft survival.

Gorczynski R, Bransom J, Cattral M, Huang X, Lei J, Min W, Wan Y, Gauldie J. Gorczynski R, et al. Among authors: wan y. Transplant Proc. 2001 Feb-Mar;33(1-2):1565-6. doi: 10.1016/s0041-1345(00)02595-1. Transplant Proc. 2001. PMID: 11267422 No abstract available.

3

Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.

Lee WC, Qiani S, Wan Y, Li W, Xing Z, Gauldie J, Fung JJ, Thomson AW, Lu L. Lee WC, et al. Among authors: wan y. Immunology. 2000 Oct;101(2):233-41. doi: 10.1046/j.1365-2567.2000.00096.x. Immunology. 2000. PMID: 11012777 Free PMC article.

4

Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression.

Wan Y, Emtage P, Foley R, Carter R, Gauldie J. Wan Y, et al. Int J Oncol. 1999 Apr;14(4):771-6. doi: 10.3892/ijo.14.4.771. Int J Oncol. 1999. PMID: 10087328

5

Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells.

Wan Y, Emtage P, Zhu Q, Foley R, Pilon A, Roberts B, Gauldie J. Wan Y, et al. Cell Immunol. 1999 Dec 15;198(2):131-8. doi: 10.1006/cimm.1999.1585. Cell Immunol. 1999. PMID: 10648127

6

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination.

Wan Y, Bramson J, Carter R, Graham F, Gauldie J. Wan Y, et al. Hum Gene Ther. 1997 Jul 20;8(11):1355-63. doi: 10.1089/hum.1997.8.11-1355. Hum Gene Ther. 1997. PMID: 9295130

7

A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.

Emtage PC, Wan Y, Bramson JL, Graham FL, Gauldie J. Emtage PC, et al. Among authors: wan y. J Immunol. 1998 Mar 1;160(5):2531-8. J Immunol. 1998. PMID: 9498799

8

Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines.

Wan Y, Bramson J, Pilon A, Zhu Q, Gauldie J. Wan Y, et al. Cancer Res. 2000 Jun 15;60(12):3247-53. Cancer Res. 2000. PMID: 10866318

9

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

Chen Y, Emtage P, Zhu Q, Foley R, Muller W, Hitt M, Gauldie J, Wan Y. Chen Y, et al. Among authors: wan y. Gene Ther. 2001 Feb;8(4):316-23. doi: 10.1038/sj.gt.3301396. Gene Ther. 2001. PMID: 11313806

10

Enhanced interleukin-2 gene transfer immunotherapy of breast cancer by coexpression of B7-1 and B7-2.

Emtage PC, Wan Y, Muller W, Graham FL, Gauldie J. Emtage PC, et al. Among authors: wan y. J Interferon Cytokine Res. 1998 Nov;18(11):927-37. doi: 10.1089/jir.1998.18.927. J Interferon Cytokine Res. 1998. PMID: 9858314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,052 results

Search Page

Filters